Weixi Tian

Find an error

Name:
Organization: University of Chinese Academy of Sciences
Department: College of Life Sciences
Title:
Co-reporter:Dan Wu, Xiaofeng Ma, Weixi Tian
Journal of Functional Foods 2013 Volume 5(Issue 2) pp:633-641
Publication Date(Web):April 2013
DOI:10.1016/j.jff.2013.01.005
Fatty acid synthase (FAS) has been recognized as a potential therapeutic target for obesity. In this study, for the first time, the inhibitory effect of pomegranate husk extract, punicalagin and ellagic acid on FAS was investigated. We found them potently inhibiting the activity of FAS with half-inhibitory concentration values (IC50) of 4.1 μg/ml (pomegranate husk extract), 4.2 μg/ml (4.50 μM, punicalagin) and 1.31 μg/ml (4.34 μM, ellagic acid), respectively. Moreover, they all exhibited time-dependent inactivation of FAS. Punicalagin and ellagic acid inhibited FAS with different mechanisms compared to previously reported inhibitors, through inactivating acetyl/malonyl transferase and β-ketoacyl synthase domains, respectively. Additionally, 100 μg/ml pomegranate husk extract, 5.24 μg/ml (5 μM) punicalagin and 4.5 μg/ml (15 μM) ellagic acid effectively reduced lipid accumulation inside FAS over-expressed 3T3-L1 adipocytes. Since FAS plays a key role in the biosynthesis pathway of fatty acid, these findings suggest that pomegranate husk extract, punicalagin and ellagic acid have potential in the prevention and treatment of obesity.Highlights► Discover novel and high active FAS inhibitors isolated from pomegranate. ► The inhibitors obviously inhibited the lipid accumulation of 3T3-L1 pre-adipocytes. ► The inhibitory activity is rather than protein precipitation by tannin.
Co-reporter:Wei Cui, Yan Liang, Weixi Tian, Mingjuan Ji, Xiaofeng Ma
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (March 2016) Volume 1861(Issue 3) pp:
Publication Date(Web):March 2016
DOI:10.1016/j.bbalip.2015.12.002
•We put forward a new hypothesis about the mechanism of fatty acid production ratio.•The geometric shape of KS domain active site is speculated as one of the determinates of fatty acid production ratio.•The binding site between KS domain and its substrate was analyzed by energy calculation and access tunnel analysis.•The most possible shape of fatty acid pathway in KS domain is a narrow channel.•The binding free energy between C16 acyl tail fatty acid and KS domain is lower than that of any other substrate analogs.Fatty acid synthase (FAS) is a multifunctional homodimeric protein, and is the key enzyme required for the anabolic conversion of dietary carbohydrates to fatty acids. FAS synthesizes long-chain fatty acids from three substrates: acetyl-CoA as a primer, malonyl-CoA as a 2 carbon donor, and NADPH for reduction. The entire reaction is composed of numerous sequential steps, each catalyzed by a specific functional domain of the enzyme. FAS comprises seven different functional domains, among which the β-ketoacyl synthase (KS) domain carries out the key condensation reaction to elongate the length of fatty acid chain. Acyl tail length controlled fatty acid synthesis in eukaryotes is a classic example of how a chain building multienzyme works. Different hypotheses have been put forward to explain how those sub-units of FAS are orchestrated to produce fatty acids with proper molecular weight. In the present study, molecular dynamic simulation based binding free energy calculation and access tunnels analysis showed that the C16 acyl tail fatty acid, the major product of FAS, fits to the active site on KS domain better than any other substrates. These simulations supported a new hypothesis about the mechanism of fatty acid production ratio: the geometric shape of active site on KS domain might play a determinate role.
Protein kinase Akt
Mitogen-activated protein kinase
Phosphatidylinositol 3-kinase
trans-Desoxyrhaponticin
S-(hydrogen malonyl)coenzyme A
(3AR,4R,5R,6AS)-4-FORMYL-2-OXOHEXAHYDRO-2H-CYCLOPENTA[B]FURAN-5-YL 4-BIPHENYLCARBOXYLATE
1,3,6-Trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one